The largest database of trusted experimental protocols

4 protocols using psbbi bla vector

1

Generation of hACE2-expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Sleeping Beauty transposase system was used for the generation of BHK-21_hACE2, CHO-K1_hACE2, HEK293-FT_hACE2, and A549_hACE2 cells as previously described (32 (link), 33 (link)). Briefly, a semi-confluent 60-mm plate was seeded with each cell line and cotransfected with 0.5 μg of pCMV(CAT)T7-SB100 (transposase vector; Addgene, no. 34879) and 5 μg of pSBbi-Bla hACE2 (transposon vector), using TransIT-LT1 Transfection Reagent (Mirus Bio), following the manufacturer’s instructions. After 24 hours, cells were transferred to a T-75 flask and selected with blasticidin (250 to 500 μg/ml) for 2 weeks. The surface expression of hACE2 was confirmed by flow cytometry using anti-human ACE2 Alexa Fluor 647–conjugated Ab (R&D Systems, no. FAB9332R). The expression was further confirmed by immunoblot using hACE2 Ab (Cell Signaling Technology, no. 4355). The ORF of hACE2 (provided by S. Best from NIAID/NIH) was cloned into pSBbi-Bla vector (Addgene, no. 60526) as described (32 (link)).
+ Open protocol
+ Expand
2

Establishment of HEK293T cell lines expressing mVenus and pendrin variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cell line that constitutively expresses mVenus (Kremers et al., 2006 (link)) harboring p.His148Gln and p.Ile152Leu (Galietta et al., 2001 (link)) was established in HEK293T cells using the Sleeping Beauty transposon system (Kowarz et al., 2015 (link)). Briefly, a cDNA encoding mVenusp.H148Q/p.I152L was cloned in a pSBbi-Bla vector (60526, addgene), and introduced to HEK293T cells together with pCMV(CAT)T7-SB100 (34879, addgene) using Effectene transfection reagent (301425, Qiagen). Transfected cells were selected in a DMEM medium (11965, Thermo Fisher Scientific) supplemented with 10% FBS and 1 µg/mL blasticidin (A11139, Thermo Fisher Scientific). Cell lines that express recombinant human pendrin constructs (both wild-type and disease-associated missense pendrin variants) in a doxycycline dosage-dependent manner were established in a similar way using a pSBtet-Pur vector (60507, addgene). Transfected cells were selected in a DMEM medium supplemented with 10% FBS and 1 µg/mL puromycin (A11138, Thermo Fisher Scientific). For I/Cl antiport assay, the pendrin-expressing pSBtet-Pur vectors were transfected in the HEK293T cell line that constitutively express mVenusp.H148Q/p.I152L (see above).
+ Open protocol
+ Expand
3

Generation of hACE2-Expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Sleeping Beauty transposase system was used for the generation of BHK-21_hACE2, CHO-K1_hACE2, HEK293-FT_hACE2 and A549_hACE2 cells as previously described 31 (link),32 (link). In brief, a semi-confluent 60 mm plate was seeded with each cell line and co-transfected with 0.5 µg of pCMV(CAT)T7-SB100 (Transposase vector, Addgene # 34879) and 5 µg of pSBbi-Bla hACE2 (Transposon vector), using TransIT-LT1 Transfection Reagent (Mirus Bio), following manufacturer instructions. After 24 h, cells were transferred to a T-75 flask and selected with 250–500 μg/ml of blasticidin for two weeks. The surface expression of hACE2 was confirmed by flow cytometry using anti-human ACE2 AlexaFluor 647-conjugated Ab (R&D Systems, # FAB9332R). The expression was further confirmed by immunoblot using hACE2 Ab (Cell Signaling Technology, # 4355). The open reading frame of hACE2 (kindly provided by Sonja Best from NIAID/NIH) was cloned into pSBbi-Bla vector (Addgene # 60526) as described 31 (link).
+ Open protocol
+ Expand
4

Generation of hACE2-expressing Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Sleeping Beauty transposase system was used for the generation of BHK-21_hACE2, CHO-K1_hACE2, HEK293-FT_hACE2 and A549_hACE2 cells as previously described31 (link),32 (link). In brief, a semi-confluent 60 mm plate was seeded with each cell line and co-transfected with 0.5 μg of pCMV(CAT)T7-SB100 (Transposase vector, Addgene # 34879) and 5 μg of pSBbi-Bla hACE2 (Transposon vector), using TransIT-LT1 Transfection Reagent (Mirus Bio), following manufacturer instructions. After 24 h, cells were transferred to a T-75 flask and selected with 250–500 μg/ml of blasticidin for two weeks. The surface expression of hACE2 was confirmed by flow cytometry using anti-human ACE2 AlexaFluor 647-conjugated Ab (R&D Systems, # FAB9332R). The expression was further confirmed by immunoblot using hACE2 Ab (Cell Signaling Technology, # 4355). The open reading frame of hACE2 (kindly provided by Sonja Best from NIAID/NIH) was cloned into pSBbi-Bla vector (Addgene # 60526) as described31 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!